Accueil > Publications > Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer
Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negativ...
Publié le 19/12/2025
We use coockies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.